Omada Health president sells 9,418 shares

Amended Form 4 for Omada Health adjusts the president’s August 12, 2026 10b5-1 plan sale to 9,418 shares, leaving 307,372 shares held directly.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reports that President Shao Wei-Li sold 9,418 shares of common stock on August 12, 2026 at $25.0167 per share in an open-market or private transaction made under a Rule 10b5-1 trading plan adopted on March 13, 2026. After this sale, Shao Wei-Li holds 307,372 shares directly. This amended Form 4 is filed solely to correct the number of shares sold, increasing it by 552 shares that were inadvertently omitted from the original report.

Insider Trade Summary 10b5-1

Net Seller: 9,418 shares

Net Sell 1 txn

Insider Shao Wei-Li

Role President

Sold 9,418 shs ($236K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	9,418	$25.0167	$236K

Holdings After Transaction: Common Stock — 307,372 shares (Direct)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. This Form 4/A is being filed solely to correct the number of shares reported as sold pursuant to the Reporting Person's 10b5-1 plan on August 12, 2026. The amount of shares sold has been adjusted to reflect the addition of 552 shares that were inadvertently omitted from the original Form 4 filed with the U.S. Securities and Exchange Commission on August 12, 2026. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 remains accurate.

Key Figures

Shares sold: 9,418 shares Sale price per share: $25.0167 per share Shares held after transaction: 307,372 shares +2 more

5 metrics

Shares sold 9,418 shares Common stock sale by the president on August 12, 2026

Sale price per share $25.0167 per share Price for the 9,418 Omada Health common shares sold

Shares held after transaction 307,372 shares Direct ownership by the president following the August 12, 2026 sale

Additional shares included in amendment 552 shares Previously omitted from the original Form 4 and now added in Form 4/A

Rule 10b5-1 plan adoption date March 13, 2026 Date the president adopted the trading plan governing this sale

Key Terms

Rule 10b5-1 trading plan, Form 4/A, Reporting Person

3 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4/A regulatory

"This Form 4/A is being filed solely to correct the number of shares"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

Reporting Person regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the insider trading Omada Health (OMDA) stock in this Form 4/A?

The filing reports a transaction by Shao Wei-Li, who serves as President of Omada Health, Inc. The report covers only this officer’s holdings and sale activity on August 12, 2026.

How many Omada Health (OMDA) shares did the president sell on August 12, 2026?

The president sold 9,418 shares of Omada Health common stock on August 12, 2026, according to the amended Form 4. This reflects an increase of 552 shares from the amount originally reported that day.

What price did Omada Health (OMDA) shares sell for in this Form 4/A transaction?

The reported sale price was $25.0167 per share for the 9,418 shares of Omada Health common stock sold by the president on August 12, 2026.

How many Omada Health (OMDA) shares does the president hold after this transaction?

After the reported sale, the president directly holds 307,372 shares of Omada Health common stock. This post-transaction ownership figure is stated in the amended Form 4.

Was the Omada Health (OMDA) insider sale under a Rule 10b5-1 plan?

Yes. A footnote states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026, indicating the trades were pre-arranged under that plan.

Why was an amended Form 4/A filed for Omada Health (OMDA)?

The amended Form 4/A was filed solely to correct the number of shares sold on August 12, 2026, adding 552 shares that were inadvertently omitted from the original Form 4. All other information remains unchanged.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:15 PM EDT Accepted by SEC EDGAR 09/04/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/12/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		S(1)		9,418(2)	D	$25.0167	307,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This Form 4/A is being filed solely to correct the number of shares reported as sold pursuant to the Reporting Person's 10b5-1 plan on August 12, 2026. The amount of shares sold has been adjusted to reflect the addition of 552 shares that were inadvertently omitted from the original Form 4 filed with the U.S. Securities and Exchange Commission on August 12, 2026. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 remains accurate.

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)